Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Actinium Pharmaceuticals, Inc · ATNM

ATNMNYSE_AMERICANCommon stockCurrentCIK 1388320Updated Nov 17, 2026

Company: Actinium Pharmaceuticals, Inc. →

Name history
Cactus Ventures, Inc. · through Mar 29, 2013

ATNM price & chart

Provider market data

Loading TradingView…

AMEX:ATNM on TradingView ↗

TradingView · Data may be delayed

About the company

Actinium is a pioneer in targeted radiotherapies designed to improve outcomes for patients with cancer. The company employs a biology-driven approach to develop differentiated radiopharmaceuticals for solid tumors and hematologic malignancies. Its mission is to transform cancer treatment through innovative radioconjugates that maximize therapeutic efficacy while minimizing toxicity to healthy tissue by combining expertise in tumor biology, translational medicine, and radiochemistry. Since inception, Actinium has focused on developing innovative radiotherapies. Its pipeline reflects this strategy across three areas: (1) solid tumor therapeutics including ATNM-400 and Actimab-A with pan-tumor potential; (2) Actimab-A as a therapeutic backbone for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in collaboration with the National Cancer Institute (NCI); and (3) targeted conditioning agents including Iomab-B for bone marrow transplant and Iomab-ACT for cell and gene therapy conditioning. ATNM-400 targets a novel antigen distinct from PSMA and has demonstrated preclinical activity across metastatic castration-resistant prostate cancer (mCRPC), non-small cell lung cancer (…

8-K · 2026-10-15 · 0001213900-26-109884

Company description from the cited filing.

In the news

Seeking Alpha

Financials

FY 2025 · USD
Net income-33,887,000USD · FY 2025
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

Operating income-36,247,000USD · FY 2025
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

Diluted EPS-1.09USD per share · FY 2025
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD56,151,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

82,114,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

40,157,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

63,017,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

89,861,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

45,438,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

68,647,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

88,352,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

51,775,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

76,899,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

81,445,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

114,192,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Property, Plant and Equipment, NetUSD226,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

412,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

700,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

271,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

460,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

268,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

317,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

496,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

295,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

364,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

550,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

604,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD53,391,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

78,660,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

36,473,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

59,928,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

86,037,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

42,132,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

65,325,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

84,057,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

47,998,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

72,904,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

76,677,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

108,910,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Assets, CurrentUSD54,366,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

79,520,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

37,740,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

61,029,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

87,068,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

43,261,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

66,456,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

85,373,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

49,381,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

74,506,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

78,263,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

110,942,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD975,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

860,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

1,267,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

1,101,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

1,031,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

1,129,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

1,131,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

1,316,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

1,383,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

1,602,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

1,586,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

1,636,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD1,215,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

1,838,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

1,373,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

1,373,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

1,990,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

1,565,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

1,530,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

2,140,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

1,754,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

1,685,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

2,289,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

2,341,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD42,367,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

43,906,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

9,855,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

44,004,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

46,026,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

43,134,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

42,953,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

44,495,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

43,941,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

44,141,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

45,066,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

47,711,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD31,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

31,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

31,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

31,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

31,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

31,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

31,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

29,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

31,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

31,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

28,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

26,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Additional Paid in CapitalUSD417,526,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

407,351,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

417,665,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

417,624,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

401,410,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

417,547,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

417,427,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

390,081,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

417,536,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

408,553,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

373,934,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

355,220,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-403,773,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

-369,174,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

-387,334,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

-398,642,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

-357,606,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

-415,235,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

-391,764,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

-346,253,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

-409,713,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

-375,826,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

-337,583,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

-288,765,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD——-60,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

——-39,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

——-20,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

———
Stockholders' Equity Attributable to ParentUSD13,784,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

38,208,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2024-09-30

30,302,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

19,013,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2025-06-30

43,835,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2024-06-30

2,304,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

25,694,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2025-03-31

43,857,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2024-03-31

7,834,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

32,758,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

36,379,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

66,481,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Liabilities and EquityUSD56,151,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

82,114,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

40,157,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

63,017,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

89,861,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

45,438,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

68,647,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

88,352,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

51,775,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

76,899,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

81,445,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

114,192,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD6,834,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

7,755,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

9,260,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

8,314,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

9,728,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

7,349,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

7,110,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

8,064,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

7,969,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

8,148,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

8,494,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

10,628,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Operating Lease, Liability, CurrentUSD599,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

549,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

741,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

589,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

540,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

726,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

579,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

540,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

711,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

569,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

530,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

494,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD531,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

1,139,000
Source

10-Q · 2024-11-14 · 0001213900-24-098534

As of 2024-09-30

595,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

685,000
Source

10-Q · 2025-08-08 · 0001213900-25-073743

As of 2025-06-30

1,284,000
Source

10-Q · 2024-08-05 · 0001213900-24-065239

As of 2024-06-30

785,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

836,000
Source

10-Q · 2025-05-09 · 0001213900-25-041614

As of 2025-03-31

1,414,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

972,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

984,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

1,553,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

—
Additional Financial Items
Deferred Revenue, NoncurrentUSD———————35,000,000
Source

10-Q · 2024-04-26 · 0001213900-24-036699

As of 2024-03-31

——35,000,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

—

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD——————29,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

47,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

173,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

197,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

790,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

699,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD——————11,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

8,874,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

9,190,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

5,292,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

3,842,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

2,795,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-5,870,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

-7,574,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

-24,580,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

-33,072,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

-47,335,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

8,644,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————-2,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

—-104,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

-11,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

-153,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

-366,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————2,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

—104,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

11,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

153,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

366,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Payment, Tax Withholding, Share-based Payment ArrangementUSD————————207,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

———
Net Cash Provided by (Used in) Financing ActivitiesUSD——————-3,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

-2,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

-217,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

29,321,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

14,870,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

23,109,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-5,864,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

-7,576,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

-24,895,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

——31,387,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——53,723,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2025-09-30

78,982,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

As of 2024-09-30

36,812,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2026-06-30

60,257,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

As of 2025-06-30

42,469,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2026-03-31

65,652,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

As of 2025-03-31

48,333,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

As of 2025-12-31

73,228,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

As of 2024-12-31

76,990,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

As of 2023-12-31

109,608,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

As of 2022-12-31

Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——————11,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

—6,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

———
Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD———————————6,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

DepreciationUSD————————173,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

197,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

207,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

152,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——1,534,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

2,827,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

2,058,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

2,624,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

1,702,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

8,938,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

15,213,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

12,076,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

13,331,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

11,999,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Investment Income, InterestUSD——561,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

1,033,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

336,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

625,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

381,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

700,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

2,360,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

3,878,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

——
Net Income (Loss) Attributable to ParentUSD——-5,131,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

-11,568,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

27,901,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

-6,878,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

-5,522,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

-15,938,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

-33,887,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

-38,243,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

-48,818,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

-33,017,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——561,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

1,033,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

336,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

625,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

381,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

700,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

2,360,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

3,878,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

3,102,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

1,087,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Operating ExpensesUSD——5,782,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

12,601,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

7,435,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

7,503,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

5,903,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

16,638,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

36,337,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

42,121,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

52,001,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

35,134,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD——173,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

173,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

218,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

173,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

218,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

173,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

707,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

691,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

691,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

584,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common StockUSD—————————29,255,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

14,612,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

—
Proceeds from Stock Options ExercisedUSD—————————75,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

262,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

—
Revenue from Contract with Customer, Including Assessed Tax—————
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

———————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——90,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

—35,000,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

———90,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

—81,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

1,030,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Operating Income (Loss)USD——-5,692,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

-12,601,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

27,565,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

-7,503,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

-5,903,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

-16,638,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

-36,247,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

-42,121,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

-51,920,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

-34,104,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-5,131,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

-11,568,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

27,901,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

-6,878,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

-5,522,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

-15,938,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

-33,887,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

-38,243,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

-48,818,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

-33,017,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.16
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

-0.37
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

0.89
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

-0.22
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

-0.18
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

-0.51
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

-1.09
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

-1.27
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

-1.83
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

-1.37
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0.16
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

-0.37
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

0.89
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

-0.22
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

-0.18
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

-0.51
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

-1.09
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

-1.27
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

-1.83
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

-1.37
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——31,195,891
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

31,071,297
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

31,399,086
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

31,195,891
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

31,237,681
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

31,195,891
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

31,195,891
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

30,070,028
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

26,604,045
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

24,141,545
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——31,195,891
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

31,071,297
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

31,406,740
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

31,195,891
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

31,237,681
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

31,195,891
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

31,195,891
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

30,070,028
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

26,604,045
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

24,141,545
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Additional Financial Items
Depreciation, Depletion and Amortization, NonproductionUSD—————————197,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

790,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

699,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——1,534,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

2,827,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

2,058,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

2,624,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

1,702,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

8,938,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

15,213,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

12,076,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

13,331,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

11,999,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD————————-33,289,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

———
Interest Income (Expense), NetUSD——————————3,102,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

1,087,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Investment Income, InterestUSD——561,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

1,033,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

336,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

625,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

381,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

700,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

2,360,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

3,878,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

——
Nonoperating Income (Expense)USD——561,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

1,033,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

336,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

625,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

381,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

700,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

2,360,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

3,878,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

3,102,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

1,087,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Operating ExpensesUSD——5,782,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

12,601,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

7,435,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

7,503,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

5,903,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

16,638,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

36,337,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

42,121,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

52,001,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

35,134,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD——173,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

173,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

218,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

173,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

218,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

173,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

707,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

691,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

691,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

584,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Other IncomeUSD——————————100,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

—
Research and Development ExpenseUSD——4,248,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2025-07-01 to 2025-09-30

9,774,000
Source

10-Q · 2025-11-14 · 0001213900-25-110979

2024-07-01 to 2024-09-30

5,377,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

4,879,000
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2025-04-01 to 2025-06-30

4,201,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2026-01-01 to 2026-03-31

7,700,000
Source

10-Q · 2026-05-08 · 0001213900-26-053980

2025-01-01 to 2025-03-31

21,124,000
Source

10-K · 2026-03-30 · 0001213900-26-036504

2025-01-01 to 2025-12-31

30,045,000
Source

10-K · 2025-03-31 · 0001213900-25-026371

2024-01-01 to 2024-12-31

38,670,000
Source

10-K · 2024-03-29 · 0001213900-24-028038

2023-01-01 to 2023-12-31

23,135,000
Source

10-K · 2023-03-31 · 0001213900-23-025597

2022-01-01 to 2022-12-31

Revenue from Contract with Customer, Including Assessed Tax—————
Source

10-Q · 2026-08-07 · 0001213900-26-086769

2026-04-01 to 2026-06-30

———————

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

ea030877001ex99-1.htm · 10-Q · 2026-11-16

Exhibit 99.1 Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, NJ 07936-1080 Robert Stanley Head US Legal & Global Legal Innovation robert.stanley@novartis.com July 31, 2026 Paul Diamond, Ph. D. Vice President, Legal and Intellectual Property Counsel Actinium Pharmaceuticals, Inc. 100 Park Avenue, 23rd Floor New York, NY 10017 pdiamond@actiniumpharma.com Dear Dr. Diamond: I am writing on behalf of Novartis Pharmaceuticals Corporation (“Novartis”) to repea…

10-Q · 2026-11-16 · 0001213900-26-120788

Read attachment ↗
ea030854201ex99-1.htm · 8-K · 2026-10-15

Exhibit 99.1 Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer NEW YORK, October 15, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (“Actinium” or the “Company”), a pioneer in the development of targeted radiotherapies, today announced the appointment of Matt David, M.D., as Chief Financial Officer. Dr. David will lead the Company’s finance, accounting, capital markets and investor relations functions…

8-K · 2026-10-15 · 0001213900-26-109884

Read attachment ↗
ea030189001ex99-1.htm · 8-K · 2026-08-14

EX-99.1 2 ea030189001ex99-1.htm PRESS RELEASE DATED AUGUST 14, 2026 Exhibit 99.1 Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update NEW YORK, August 14, 2026 /PRNewswire/ - Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced advances across its Actimab-A program, including recently acquired patents adding …

8-K · 2026-08-14 · 0001213900-26-090232

Read attachment ↗
ea029269101ex99-1.htm · 8-K · 2026-05-29

EX-99.1 2 ea029269101ex99-1.htm PRESS RELEASE DATED MAY 29, 2026 Exhibit 99.1 Actinium Pharmaceuticals to Present ATNM-400 Program Update at SNMMI 2026 Conference on May 31-June 2 and Provides NYSE American Listing Standards Notice NEW YORK, May 29, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced it will provide a program update on its first-in-class Actinium-225 (22…

8-K · 2026-05-29 · 0001213900-26-062935

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.